Scantek Medical's "BreastCare" Evaluation of Its Potential Usefulness in Breast Cancer Screening At European Conference on Screening and Early Detection of Cancer.Technology & Medical Editors DENVILLE, N.J.--(BUSINESS WIRE)--March 9, 2000 Scantek Medical, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :SKML SKML Singapore Kadayanallur Muslim League .OB) announced today, that an evaluation of its BreastCare (TM) Differential Temperature Sensor for its potential usefulness in breast cancer screening This article or section recently underwent a major revision or rewrite and needs further review. You can help! X-ray mammography Mammography is still the modality of choice for screening of early breast cancer, since it is relatively fast, reasonably accurate, and was presented at the European Conference on Screening and Early Detection of Cancer in Vienna, Austria. The Federation of European Cancer Societies The Federation of European Cancer Societies or FECS is an international non-profit association that co-ordinates collaboration between European societies active in different fields of cancer research, prevention and treatment with the ultimate goal of providing the best organized the Conference. President of the Conference was Professor Umberto Veronesi, MD, Scientific Director of the European Institute of Oncology The European Institute of Oncology (Italian: Istituto Europeo di Oncologia, IEO) is a non-profit comprehensive cancer centre located in Milan, Italy that is active in three areas:
The abstract, by epidemiologist, Dr. Alvaro L. Ronco, entitled; "Evaluation of a breast temperature sensitive pad and its potential usefulness in screening" was released to the Conference. The abstract was co authored with Dr. Alvaro L. Ronco and Dr. Jose A. Carambula, both affiliated with PRONOCAM (National Breast Cancer Program), Ministry of Public Health, Montevideo, Uruguay and Dr. Alfredo Barros, President of the Brazilian Society of Mastology, Brazil. The results of the binational bi·na·tion·al adj. Of, relating to, or involving two nations. Uruguayan-Brazilian multicenter clinical study (36 institutions) with 1626 women were presented on the application of BreastCare, a new method of functional thermometric evaluation of breasts, based on the knowledge that metabolically more active tissue can be suspicious of neoplastic neoplastic /neo·plas·tic/ (ne?o-plas´tik) 1. pertaining to a neoplasm. 2. pertaining to neoplasia. neoplastic pertaining to neoplasia or a neoplasm. growth. PRONOCAM and the Brazilian Society of Mastology coordinated these studies. All women had performed a Clinical Breast Examination, mammography and in 181, a biopsy was performed. With a mammography suspicious of malignancy, followed with a biopsy ("Gold Standard") positive for cancer (in situ or invasive), parameters of diagnostic predictive capabilities of the BreastCare device have been calculated, either isolated or combined with Clinical Breast Examinaton. In the evaluation of the results, a high diagnostic accuracy has been achieved, mainly based on BreastCare's high Negative Predictive Value The negative predictive value is the proportion of patients with negative test results who are correctly diagnosed. Worked example
Condition (as determined by "Gold standard") True False (95%). When BreastCare was used in combination with Clinical Breast Examination the accuracy of both methods compared to mammography was 97.2%. The results indicated the remarkable possible potential of the device for developing countries that offer limited availability of mammography for the female population. The conclusion of the evaluation, that when BreastCare is used in combination with Clinical Breast Examination, resulting in high level of accuracy, could be a criteria for selecting women to have or not to have a mammogram performed Mr. Sagi, President and Chief Executive Officer of the Company, stated, "The Company is very proud of the high quality work presented, which met international requirements for acceptance by the European Conference." The BreastCare/BreastAlert Differential Temperature Sensor is a non-invasive, easy to use, low cost, and 15-minute test. The device is cleared for marketing by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. in the United States for use by the physician in adjunct with physical examination, including palpation palpation /pal·pa·tion/ (pal-pa´shun) the act of feeling with the hand; the application of the fingers with light pressure to the surface of the body for the purpose of determining the condition of the parts beneath in physical diagnosis. , mammography, and other established screening modalities for the detection of breast disease. Currently, the device is being used in South America and Europe. Subject to certain financing, which the Company is seeking to obtain, the Company plans to relaunch the BreastCare/ BreastAlert in the United States. Scantek Medical, Inc. is a high-tech medical Company engaged in developing, manufacturing, selling, and licensing of products and devices to assist in the diagnosis and early detection of disease. At the present time, the Company is focused on manufacturing, selling, and licensing the BreastCare/BreastAlert device globally. Certain Statements in this press release with respect to future expectations and plans may be regarded as "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such statements involve risks and uncertainties and are subject to change at any time. The Company's actual results could differ materially from such statements. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion